David Terry
About David Terry
David Terry is the Regional Business Director at both Bristol-Myers Squibb and ZymoGenetics, with a long-standing career in the pharmaceutical and biotechnology industries.
Title and Current Roles
David Terry currently serves as Regional Business Director at both Bristol-Myers Squibb and ZymoGenetics. In these roles, he oversees regional operations and business strategies. His tenure in these positions highlights his extensive experience and leadership within the pharmaceutical and biotechnology sectors.
Career Background
David Terry has a robust background in the pharmaceutical and biotechnology industries. He worked at Novo Nordisk A/S as Regional Director from 1999 to 2007, spanning 8 years. Earlier, he served as Marketing Director for Blood Management Systems at Bayer HealthCare from 1973 to 1991, a term lasting 18 years. His career reflects significant roles at well-known industry players.
Education and Expertise
David Terry holds a Bachelor of Arts degree in Business Administration and Management from St. Norbert College and a Master of Business Administration (MBA) from St. Mary's College of California. These educational credentials underpin his expertise and strategic acumen in business administration and management.
Experience with RECOTHROM
David Terry has been actively involved with the product RECOTHROM since the acquisition of ZymoGenetics by Bristol-Myers Squibb in October 2011. His role in this product's management is a testament to his expertise and ongoing contributions to the biotechnology field.
Over a Decade in Current Role
David Terry has over a decade of experience in his current role as Regional Business Director, starting in January 2010. This long tenure demonstrates his enduring commitment and leadership capabilities within the industry.